We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Preservative Stabilizes Residual White Cells in Leuko-Reduced Samples

By LabMedica International staff writers
Posted on 20 May 2009
A preservative specifically stabilizes residual white blood cells (rWBCs) in leuko-reduced red blood cell samples.

Compatible with commercially available kits, Leuko Preserve is intended for detection and enumeration of rWBCs by flow cytometric analysis. More...
Flow cytometric enumeration of rWBCs in leuko-reduced blood components must be implemented within 48 hours. Occasionally, problems occur making this difficult.

Streck's (Omaha, NE, USA) Leuko Preserve stabilizes rWBCs for up to seven days following leuko-reduction, extending the timeframe for enumeration. This reduces concerns of sample backlogs, instrument problems, and shipping delays.

Additional Streck cell stabilization products include Streck Cell Preservative for the preservation of bone marrow and tissue samples; Cyto-Chex BCT (Blood Collection Tube) for the preservation of whole blood samples for immunophenotyping by flow cytometry; and Cell-Free DNA BCT, a new blood collection tube for the preservation of cell-free plasma DNA. Cell-Free DNA BCT is for research use only.

Streck has also increased the stability of its three-part Para Check whole blood hematology control. Manufactured specifically for the Sysmex KX-21, pocH-100i, and the SweLab AC920EO, the three-part control now offers closed-vial stability of 132 days. The extended closed-vial stability will allow customers to maintain a quarterly ordering schedule, decreasing shipping costs and increasing the ILQC (interlaboratory quality control) peer groups for each instrument on the assay. Para Check is available in a 2.5-ml or 3.5-ml vial with a pierceable cap to accommodate both open- and closed-mode systems.

STATS, a free interlaboratory quality control program, is offered to all Para Check customers. STATS produces relevant peer group comparison reports and graphs with a quick turnaround time. Data can be submitted by mail, fax or e-mail. The reports include customer data, peer group averages, and computer-generated Levey-Jennings graphs.

Streck is an independent developer and manufacturer of controls for the clinical laboratory.

Related Links:

Streck



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.